English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
American Academy Of Neurology
Sam Jackson
| Apr 25, 2023
Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson
| Apr 25, 2023
New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'
Press release submission
| May 2, 2019
AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley
| May 16, 2017
Immunosuppressive drug cladribine may slow progression of MS
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Robert Hadley
| May 3, 2017
Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp
| May 22, 2016
New ALS research announced at annual conference
Amanda Rupp
| Apr 21, 2016
ALS Association announces new research fellowships
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
